期刊
JOURNAL OF NUCLEAR MEDICINE
卷 58, 期 9, 页码 1490-1497出版社
SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.116.189290
关键词
epilepsy; cognition; anticonvulsant; monoamine receptor; positron emission tomography (PET)
资金
- National Key Research and Development Program of China [2016YFA0100900]
- National Key Basic Research Program of China [2013CB329506]
- National Science Foundation of China (NSFC) [81425015, 81271601]
- Zhejiang Provincial Natural Science Foundation of China [LR13H180001]
A landmark study from the Institute of Medicine reported that the assessment of cognitive difficulties in children with epilepsy is timely and imperative. Anticonvulsant-induced cognitive impairment could influence the quality of life more than seizure itself in patients. Although the monoaminergic system is involved in the regulation of cognitive process, its role in anticonvulsant-induced cognitive impairment remains unclear. Methods: To explore in vivo monoamine receptor binding activity in patients with anticonvulsant-induced cognitive impairment, each patient underwent PET imaging with both monoamine receptor binding agent C-11-N-methylspiperone and glucose metabolic agent F-18-FDG. Tests of intelligence quotient (IQ), including verbal IQ (VIQ), performance IQ (PIQ), and full-scale IQ (FSIQ), were performed in each patient. Results: Compared with the patients with monotherapy, patients with polytherapy had significantly lower VIQ, PIQ, and FSIQ (P < 0.01 in each comparison), as well as significantly lower monoamine receptor activities detected in the caudate nucleus, prefrontal cortex, dorsal anterior cingulate cortex, and amygdale (P < 0.05 in each comparison). However, regarding the glucose metabolism, there was no significant difference found in patients with monotherapy or polytherapy (P > 0.05). Conclusion: Monoamine receptor PET imaging could be a promising in vivo imaging biomarker for mapping anti-convulsant-induced cognitive impairment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据